Chronic kidney disease (CKD) patients, especially diabetic patients with SARS-CoV-2, are at a higher risk of AKI due to baseline upregulation of angiotensin-converting enzyme (ACE) and downregulation of ACE-2 protein. This evidence concerns the gene ACE and chronic kidney disease.